TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2015

A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade(®)) in Healthy Subjects.

Donghoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.